Migraine is a common disabling condition likely to be associated with dysfunction of brain
pathways involved in pain and other sensory modalities. A cardinal, indeed signature, feature …

… Drafting of the manuscript: Afridi, Friston, and Goadsby. Critical revision of the manuscript
for important intellectual content: Afridi, Giffin, Kaube, Ward, Frackowiak, and Goadsby. …

Most patients with primary headache syndromes who have frequent attacks of pain have
tenderness in the sub-occipital region. Injection of the greater occipital nerve (GON) with local …

… Afridi, MD, FRCSC; Mostafa M. Elhilali, MD, FRCSC; and the PROSPECT Study Group* …
Afridi is chief of urology, St. Paul's Hospital, Saskatoon, Sask.; and Dr. Elhilali is professor of …

Autism is a neuro-developmental syndrome that affects 0.1–0.5% of the population. It has
been proposed that alterations in neuronal circuitry and/or neuronal signaling are responsible …

Zika virus (ZIKV) has become a global public health emergency due to its rapidly expanding
range and its ability to cause severe congenital defects such as microcephaly. However, …

Objective: The aim of our study was to test the hypothesis that ketamine would affect aura in
a randomized controlled double-blind trial, and thus to provide direct evidence for the role of …

Purpose To evaluate the incidence of mosaicism in de novo neurofibromatosis 2 (NF2).
Methods Patients fulfilling NF2 criteria, but with no known affected family member from a …

Background Neurofibromatosis 1 (NF1) is an inherited, multi-system, tumour suppressor
disorder with variable complications that cause psychological distress and social isolation. The …

Bevacizumab is considered an established part of the treatment strategies available for
schwannomas in patients with Neurofibromatosis type 2 (NF2). In the UK, it is available through …